These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 19446616)

  • 1. Density functional calculations on meloxicam-beta-cyclodextrin inclusion complexes.
    Snor W; Liedl E; Weiss-Greiler P; Viernstein H; Wolschann P
    Int J Pharm; 2009 Nov; 381(2):146-52. PubMed ID: 19446616
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improvement of drug loading onto ion exchange resin by cyclodextrin inclusion complex.
    Samprasit W; Rojanarata T; Akkaramongkolporn P; Ngawhirunpat T; Sila-on W; Opanasopit P
    Drug Dev Ind Pharm; 2013 Nov; 39(11):1672-80. PubMed ID: 23078590
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of inclusion complexation of meloxicam with β-cyclodextrin- and β-cyclodextrin-based nanosponges on solubility, in vitro release and stability studies.
    Shende PK; Gaud RS; Bakal R; Patil D
    Colloids Surf B Biointerfaces; 2015 Dec; 136():105-10. PubMed ID: 26364091
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An optimized commercially feasible milling technique for molecular encapsulation of meloxicam in β-cyclodextrin.
    Bandarkar FS; Vavia PR
    Drug Dev Ind Pharm; 2011 Nov; 37(11):1318-28. PubMed ID: 21506882
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of meloxicam formulations utilizing ternary complexation for solubility enhancement.
    Awasthi SS; Kumar TG; Manisha P; Preeti Y; Kumar SS
    Pak J Pharm Sci; 2011 Oct; 24(4):533-8. PubMed ID: 21959817
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Formulation and evaluation of meloxicam oral disintegrating tablet with dissolution enhanced by combination of cyclodextrin and ion exchange resins.
    Samprasit W; Akkaramongkolporn P; Ngawhirunpat T; Rojanarata T; Opanasopit P
    Drug Dev Ind Pharm; 2015 Jun; 41(6):1006-16. PubMed ID: 24865111
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development and evaluation of fast-dissolving tablets of meloxicam-β-cyclodextrin complex prepared by direct compression.
    Obaidat AA; Obaidat RM
    Acta Pharm; 2011 Mar; 61(1):83-91. PubMed ID: 21406346
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Host-guest complexation of oxicam NSAIDs with beta-cyclodextrin.
    Banerjee R; Chakraborty H; Sarkar M
    Biopolymers; 2004 Nov; 75(4):355-65. PubMed ID: 15372483
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preparation of meloxicam-β-cyclodextrin-polyethylene glycol 6000 ternary system: characterization, in vitro and in vivo bioavailability.
    Radia O; Rogalska E; Moulay-Hassane G
    Pharm Dev Technol; 2012; 17(5):632-7. PubMed ID: 21428700
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Meloxicam complexation with beta-cyclodextrin: influence on the anti-inflammatory and ulcerogenic activity.
    Baboota S; Agarwal SP
    Pharmazie; 2003 Jan; 58(1):73-4. PubMed ID: 12622261
    [No Abstract]   [Full Text] [Related]  

  • 11. Tablet formulation containing meloxicam and beta-cyclodextrin: mechanical characterization and bioavailability evaluation.
    Ghorab MM; Abdel-Salam HM; El-Sayad MA; Mekhel MM
    AAPS PharmSciTech; 2004 Jul; 5(4):e59. PubMed ID: 15760056
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Formulation and investigation of differently charged β-cyclodextrin-based meloxicam potassium containing nasal powders.
    Varga P; Németh A; Zeiringer S; Roblegg E; Budai-Szűcs M; Balla-Bartos C; Ambrus R
    Eur J Pharm Sci; 2024 Nov; 202():106879. PubMed ID: 39154714
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Meloxicam β-cyclodextrin transdermal gel: physicochemical characterization and in vitro dissolution and diffusion studies.
    Rasool BK; Gareeb RH; Fahmy SA; Rasool AA
    Curr Drug Deliv; 2011 Jul; 8(4):381-91. PubMed ID: 21453259
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A computational study of the inclusion of β-cyclodextrin and nicotinic acid: DFT, DFT-D, NPA, NBO, QTAIM, and NCI-RDG studies.
    Belhouchet HR; Abbaz T; Bendjedou A; Gouasmia A; Villemin D
    J Mol Model; 2022 Oct; 28(11):348. PubMed ID: 36208396
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Physicochemical characterization and dissolution properties of meloxicam-cyclodextrin binary systems.
    Naidu NB; Chowdary KP; Murthy KV; Satyanarayana V; Hayman AR; Becket G
    J Pharm Biomed Anal; 2004 Apr; 35(1):75-86. PubMed ID: 15030882
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Meloxicam and meloxicam-beta-cyclodextrin complex in model membranes: effects on the properties and enzymatic lipolysis of phospholipid monolayers in relation to anti-inflammatory activity.
    Wiecław K; Korchowiec B; Corvis Y; Korchowiec J; Guermouche H; Rogalska E
    Langmuir; 2009 Feb; 25(3):1417-26. PubMed ID: 19123793
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tablet formulation studies on nimesulide and meloxicam-cyclodextrin binary systems.
    Nalluri BN; Chowdary KP; Murthy KV; Becket G; Crooks PA
    AAPS PharmSciTech; 2007 May; 8(2):Article 36. PubMed ID: 17622114
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug-excipient compatibility assessment of solid formulations containing meloxicam.
    da Silveira LM; Fiorot AB; Xavier TP; Yoshida MI; de Oliveira MA
    Eur J Pharm Sci; 2018 Jan; 112():146-151. PubMed ID: 29174987
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The influence of the preparation methods on the inclusion of model drugs in a beta-cyclodextrin cavity.
    Salústio PJ; Feio G; Figueirinhas JL; Pinto JF; Cabral Marques HM
    Eur J Pharm Biopharm; 2009 Feb; 71(2):377-86. PubMed ID: 18977436
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of ternary complexes of meloxicam-HPbetaCD and PVP or L-arginine prepared by the spray-drying technique.
    El-Maradny HA; Mortada SA; Kamel OA; Hikal AH
    Acta Pharm; 2008 Dec; 58(4):455-66. PubMed ID: 19103579
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.